Has Donald McSweyn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,428 in general payments to Donald McSweyn, MD across 698 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Donald McSweyn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Donald McSweyn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Donald McSweyn, MD

Cardiovascular Disease · Kansas City, KSNPI 1013973288

Payments from drug & device makers

$12,428in general payments, 2019–2025

Across 698 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
Novartis$1K
Amgen$1K
Sanofi-aventis U.S. LLC$938
Boehringer Ingelheim$834
E.r. Squibb & Sons, L.L.C.$771
plus $6K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	92	$1,610
Novartis	92	$1,182
Amgen	62	$1,092
Sanofi-aventis U.S. LLC	58	$938
Boehringer Ingelheim	56	$834
E.r. Squibb & Sons, L.L.C.	47	$771
Merck	45	$708
AstraZeneca	38	$676
Biotronik Inc.	10	$628
Pfizer	31	$538
Bayer	24	$454
Boston Scientific	28	$438
Actelion Pharmaceuticals US, Inc.	17	$314
Kestra Medical Technology Services, Inc.	8	$230
Medtronic(2 entities)	3	$216
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	8	$192
Irhythm Technologies, Inc.	8	$177
Alnylam Pharmaceuticals Inc.	8	$171
Kowa Pharmaceuticals America, Inc.	10	$156
Bardy Diagnostics, Inc.	5	$130
Novo Nordisk	6	$126
Abbott	4	$116
Cvrx, Inc.	5	$113
Kiniksa Pharmaceuticals, Ltd.	4	$94
Kiniksa Pharmaceuticals International, PLC	5	$83
Amarin Pharma, Inc.	5	$82
Regeneron Healthcare Solutions, Inc.	3	$58
Angiodynamics, Inc.	1	$47
Lexicon Pharmaceuticals, Inc.	2	$37
Scpharmaceuticals Inc.	2	$34
Amryt Pharma Holdings Ltd	2	$31
Tactile Systems Technology Inc	1	$22
Sanofi	1	$22
Edwards Lifesciences	1	$22
Penumbra, Inc.	1	$16
Aegerion Pharmaceuticals, Inc.	1	$16
GSK	1	$15
Bracco Diagnostics Inc.	1	$14
Cook Medical LLC	1	$13
Esperion Therapeutics, Inc.	1	$12

How this compares

$12,428 in reported general payments places this provider in the 80th percentile of 175 cardiovascular disease providers in Kansas.

See all cardiovascular disease providers in Kansas →

Medicare billing

Part B allowed, 2024

$148,538

Medicare patients

1,071

Services billed

2,519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Kansas City

Mazhar AfaqKansas City$136K
Thomas RosamondKansas City$60K
Timothy BeaverKansas City$22K
Jayant NathKansas City$18K
Hector RodriguezKansas City$13K
Jean-Alfred ThomasKansas City$11K
Seyedhamed HosseinidehkordiKansas City$8K
Mohammad AlarfajKansas City$7K
Matthew KellingKansas City$6K
Siri NeelatiKansas City$6K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →